Patient Selection & Adverse Event Management for Solid Tumor TIL Therapy
Time: 1:30 pm
day: Conference Day Two - Track B - PM
Details:
- Criteria for appropriate patient selection
- Considerations for bridging therapy
- Identification and management of treatment-related adverse events
